We are proud to share that NanoCarbonTech participated in NanoTech Poland 2026 in Poznań, where the official launch of the NeuroCardioChip project, funded under the ERA4Health programme, took place.
NeuroCardioChip is an ambitious international research initiative that brings together expertise in biomedicine, advanced materials, microfluidics, and bioengineering. The project is designed to advance our understanding of neuro-cardiac dysfunction while developing a scalable and translational platform for studying complex diseases, creating new opportunities for both cardiovascular and neurological research.
We are honored to be part of this outstanding consortium, coordinated by Dr. Albano Meli (Inserm, University of Montpellier, France), alongside partners from the University of Latvia, Adam Mickiewicz University.
As a consortium partner, NanoCarbonTech is excited to contribute its expertise in advanced nanomaterials and MXene-based technologies to support the development of innovative models for investigating complex neuro-cardiac disorders. We believe this collaboration has great potential to accelerate scientific discoveries and pave the way for future clinical applications.
The kick-off meeting, held during NanoTech Poland 2026, was marked by inspiring discussions, scientific enthusiasm, and a shared commitment to developing innovative solutions that connect fundamental research with real-world healthcare challenges.
We are looking forward to working closely with our partners over the coming years and to the exciting discoveries and innovations that NeuroCardioChip will deliver.
A sincere thank you to all consortium members, ERA4Health, and NCBR Poland for supporting this important initiative.